Publications:
Other Publications
Jul
2024
Significant Mitral Regurgitation After Permanent Right Ventricular Pacemaker Implantation: Prognostic Implications.
Nabeta T, Galloo X, Tops L, Stassen J, Marsan NA, van der Bijl P, Bax JJ.
Am J Cardiol. 2024 Jul 1;222:78-86. doi: 10.1016/j.amjcard.2024.05.003. Epub 2024 May 8.
PMID: 38723856
Jun
2024
Cutibacterium species valvular and cardiac device-related infective endocarditis: contemporary data from the GAMES prospective cohort (2008-2023)
Alonso-Menchén D, Marín-Arriaza M, Villamarín M, Fernández-Hidalgo N, López-Azor JC, Calderón-Parra J, Águila Fernández-Paniagua E, Hidalgo-Tenorio C, de Alarcón A, Goenaga-Sánchez MÁ, Rodríguez-Esteban MÁ, García Vázquez E, Grillo S, Bouza E, Muñoz P.
Clin Infect Dis. 2024 Jun 24:ciae334. doi: 10.1093/cid/ciae334. Online ahead of print.
PMID: 38913722
Jun
2024
Fifteen years of subcutaneous implantable cardioverter-defibrillator therapy: Where do we stand, and what will the future hold?
Dijkshoorn LA, Smeding L, Pepplinkhuizen S, de Veld JA, Knops RE, Olde Nordkamp LRA.
Heart Rhythm. 2024 Jun 20:S1547-5271(24)02741-3. doi: 10.1016/j.hrthm.2024.06.028. Online ahead of print.
PMID: 38908460 Review.
Jun
2024
Chronic kidney disease and transvenous cardiac implantable electronic device infection-is there an impact on healthcare utilization, costs, disease progression, and mortality?
Wright DJ, Trucco ME, Zhou J, Wolff C, Holbrook R, Margetta J, El-Chami MF.
Europace. 2024 Jun 19:euae169. doi: 10.1093/europace/euae169. Online ahead of print.
PMID: 38890126
Jun
2024
Outcomes of complete removal versus conservative therapy in cardiac implantable electronic device infections – A systematic review and Meta-analysis.
Caldonazo T, Fischer J, Spagnolo A, Dell'Aquila M, Kirov H, Tasoudis P, Treml RE, Vervoort D, Sá MP, Doenst T, Diab M, Hagel S.
Int J Cardiol. 2024 Jun 13;411:132264. doi: 10.1016/j.ijcard.2024.132264. Online ahead of print.
PMID: 38878871